Mediworld Pharma Private Limited
About Mediworld Pharma Private Limited
Data last updated:
Mediworld Pharma Private Limited is a private limited company based in Davanagere, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2013PTC068953. Its GSTIN is 29AAICM6386J1ZQ (Karnataka).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Vinaya Lakshminarayana Acharya and Basavaraju Gurupadappa Hedni.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No.480 At Nittuvali R.S No. 67 Hadadi Road, Davanagere, Karnataka, India – 577002.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.98 Cr, a decline of 50% compared to the previous year. For the same year it recorded a net profit of ₹11.9 Lakh (net margin 6%) and EBITDA of ₹16.81 Lakh (EBITDA margin 8.5%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 7% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mediworld Pharma Private Limited's registered office is in Davanagere, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressDoor No.480 At Nittuvali R.S No. 67 Hadadi Road, Davanagere, Karnataka, India – 577002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mediworld Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediworld Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mediworld Pharma Private Limited, buy the company report.
Financials of Mediworld Pharma Private Limited
FY 2025 filings availableMediworld Pharma Private Limited reported revenue of ₹1.98 Cr (down 50% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 50% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediworld Pharma Private Limited, buy the company report.
Board of directors of Mediworld Pharma Private Limited
Mediworld Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinaya Lakshminarayana Acharya Also directs: Atri Datta Communications Private Limited | Director | 06 May 2013 | 13 Years 5 Months | Current |
| Basavaraju Gurupadappa Hedni | Director | 30 Jan 2015 | 11 Years 9 Months | Current |
| Sachina Kapu Acharya Also directs: SRG Healthcare Private Limited, Venkatesh Medico Private Limited, Akp Healthcare Private Limited and 1 more | Director | 06 May 2013 | 13 Years 5 Months | Current |
Shareholding
The shareholding of Mediworld Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mediworld Pharma Private Limited, buy the company report.
Legal cases
Mediworld Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, KARNATAKA | Court case (CRL.P) | Filed against the company by individuals | Disposed |
To see the full case history of Mediworld Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediworld Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mediworld Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Mediworld Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICM6386J1ZQ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mediworld Pharma Private Limited, buy the company report.
Recent activity
Mediworld Pharma Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Sachina Kapu Acharya ceased to be Managing Director on 01 Sep 2025.
Frequently asked questions
Mediworld Pharma is an active private limited company based in Davanagere, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 May 2013 (13+ years old) and is registered under CIN U24239KA2013PTC068953.
Mediworld Pharma has 3 current directors:
- Vinaya Lakshminarayana Acharya - Director
- Basavaraju Gurupadappa Hedni - Director
- Sachina Kapu Acharya - Director
The latest financial statements of Mediworld Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mediworld Pharma is 29AAICM6386J1ZQ, registered in Karnataka.
The CIN (Corporate Identification Number) of Mediworld Pharma is U24239KA2013PTC068953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediworld Pharma has 1 court case on record: 1 filed against it.
Mediworld Pharma was incorporated on 06 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Sachina Kapu Acharya ceased to be Managing Director on 01 Sep 2025. Somashekar Basavana Gowda ceased to be Director on 30 Sep 2019. Shashank Srinivas Srivatsa ceased to be Director on 01 Sep 2019. Mediworld Pharma has 7 board changes on record in total.
The registered office of Mediworld Pharma is at Door No.480 At Nittuvali R.S No. 67 Hadadi Road, Davanagere, Karnataka, India – 577002.
Mediworld Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
